1 INTRODUCTION
COVID-19 is a viral infection induced by the coronavirus of severe
respiratory syndrome (SARS-CoV-2), that represents a serious health
problem worldwide; due to its association with various
pathophysiological processes such as: inflammation, increased
proinflammatory cytokines, and cell death, which could be closely
related to redox imbalance or oxidative stress.1 The
high risk of severity and mortality from SARS-CoV-2 infection or
COVID-19 disease has been associated with several clinical indicators
such as: lymphocytopenia, increased D-dimer, increased serum ferritin,
and high titers IL-6.1,2
The inflammatory response induced by SARS-CoV-2 can generate an effect
of cellular oxidative stress, which induces an increase in circulatory
inflammatory mediators, including cytokines, produced through redox
pathway activation in patients with sepsis.3,4Because, oxidative stress and inhibition of mitochondrial activity may
be an alternative to explain the tissue injury associated with
COVID-19-induced damage to endothelial, alveolar, and cardiac cells,
among other.5,6 We consider it vitally important that
health professionals can analyze and understand a little more about
these pathophysiological mechanisms, to evaluate and design new
protocols that allow a better prognosis for patients.
According to tissue damage, accumulation of inflammatory cells
associated with endothelial tissue has been reported, as well as
apoptotic bodies in alveolar cells and others.7 Thus,
it is postulated the accumulation of mononuclear cells in the lung and
in the small pulmonary vessels induce congestion and therefore
endothelial tissue damage associated with the lung.8The endothelial dysfunction is a main determinant of microvascular
dysfunction, which is associated with the processes of inflammation and
oxidative stress, that potentiate tissue edema associated with a
pro-coagulant state.6,9
The SARS-CoV-2 induce an explosion of inflammatory cytokines, reactive
oxygen species (ROS), and cell death-induced by this cell events is a
cause which can result in significant endothelial and multi-organ
damage, so the regulation of oxidative stress is
essential.3,4,7 Thus, modulation of oxidative stress
may be able to prevent the cellular and tissue injury and development
severe disease symptoms in coronavirus patients by reduce the
immuno-pathology of coronavirus infection on patients’ health after the
active phase of the infection is over, so that, if we could reduce or
modulate cellular toxic effects, it would make COVID-19 disease more
controllable.9,11
Therefore, this study aimed to evaluate the association between
different biomarkers of oxidative stress with parameters of
mitochondrial and cellular function to evaluate the relationship between
oxidative stress and leukocyte function in patients with COVID-19. This
process contributes to the understanding of the possible link between
oxidative stress and the risk of pathogenesis, severity and mortality in
patients affected by SARS-CoV-2 infection.